Cargando…
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.
Resistance to cytotoxics precludes the successful treatment of many solid tumours. Inhibition of DNA synthesis in normal tissues with antimetabolites such as hydroxyurea (HU) may be a useful means of improving the selective uptake of toxic thymidine analogues by the relatively resistant tumour cells...
Autores principales: | Philip, P. A., Kaklamanis, L., Carmichael, J., Tonkin, K., Morrison, H., Gatter, K., Harris, A. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968348/ https://www.ncbi.nlm.nih.gov/pubmed/8471420 |
Ejemplares similares
-
Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
por: Neshasteh-Riz, A., et al.
Publicado: (1998) -
The Toxicity of (125)IUdR in Cultured Mouse BP8 Tumour Cells
por: Porteous, D. D.
Publicado: (1971) -
Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage
por: Bayart, Emilie, et al.
Publicado: (2017) -
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.
por: Philip, P. A., et al.
Publicado: (1991) -
Assessment of Drug Sensitivity of Human Leukaemic Myeloblasts: I. Labelling Human Myeloblasts with (125)IUdR for Survival Studies in Mice
por: FalcãO, R. P., et al.
Publicado: (1977)